Latest Articles

Publication Date
Cadonilimab Plus Lenvatinib Proves Active in Platinum-Pretreated, Advanced Endometrial Cancer - OncLive

Cadonilimab Plus Lenvatinib Proves Active in Platinum-Pretreated, Advanced Endometrial Cancer OncLive

Published: March 15, 2025, 3:35 p.m.
Nivolumab Yields High Clinical CR Rates Allowing for Surgery Omission in dMMR/MSI-H Endometrial Cancer - OncLive

Nivolumab Yields High Clinical CR Rates Allowing for Surgery Omission in dMMR/MSI-H Endometrial Cancer OncLive

Published: March 15, 2025, 3:27 p.m.
FIGURE 1 MTFR2 is highly expressed in endometrial carcinoma and is a... - ResearchGate

FIGURE 1 MTFR2 is highly expressed in endometrial carcinoma and is a... ResearchGate

Published: March 14, 2025, 10:44 p.m.
Vaginal dysbiosis increases risk of endometrial polyp recurrence after hysteroscopic polypectomy: Study - Medical Dialogues

Vaginal dysbiosis increases risk of endometrial polyp recurrence after hysteroscopic polypectomy: Study Medical Dialogues

Published: March 14, 2025, 3 p.m.
Palbociclib Plus Letrozole May Increase PFS for ER+ Endometrial Cancer - www.oncnursingnews.com/

Palbociclib Plus Letrozole May Increase PFS for ER+ Endometrial Cancer www.oncnursingnews.com/

Published: March 14, 2025, 2:07 p.m.
(PDF) Comparison of diagnostic tests for chronic endometritis and endometrial dysbiosis in recurrent implantation failure: Impact on pregnancy outcomes - ResearchGate

(PDF) Comparison of diagnostic tests for chronic endometritis and endometrial dysbiosis in recurrent implantation failure: Impact on pregnancy outcomes ResearchGate

Published: March 14, 2025, 3:17 a.m.
Robotic-assisted laparoscopy increases endometrial cancer survival rates - Contemporary Obgyn

Robotic-assisted laparoscopy increases endometrial cancer survival rates Contemporary Obgyn

Published: March 13, 2025, 5:15 p.m.
Untangling Race-based Disparities in Endometrial Cancer - Medscape

Untangling Race-based Disparities in Endometrial Cancer Medscape

Published: March 13, 2025, 8:56 a.m.
Dr Wagar on the Evolution of Advanced/Recurrent Endometrial Cancer Management - OncLive

Dr Wagar on the Evolution of Advanced/Recurrent Endometrial Cancer Management OncLive

Published: March 12, 2025, 9:07 p.m.
Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer - Business Wire

Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer Business Wire

Published: March 12, 2025, 5:34 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!